(Q73132072)
Statements
Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma (English)
Stadtmauer E
Juweid ME
Hajjar G
Sharkey RM
Suleiman S
Swayne LC
Alavi A